glp 1 iih Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain Journal club: GLP-1 receptor agonists

New and emerging therapies for pulmonary arterial hypertension

The regulatory landscape for BPC-157 includes its listing by the World Anti-Doping Agency (WADA) as a prohibited substance, reflecting concerns about its potential to enhance sports performance and accelerate recovery from musculoskeletal injury models

Bevilacqua A, et al

High-fat-fed ApoE / mice exhibit larger atherosclerotic plaques, severe ferroptosis, increased NOX production, and reduced GSH and xCT expression in the thoracic aorta compared to wild-type mice ( / mice

The Hims & Hers ad is shrewd in its heavy-handedness

Longitudinal studies, such as the NESARC, have attempted to address this complexity by tracking temporal relationships